Journal Home
Search for

Volume 52, Issue 2, Pages 160-166 (February 2010)


View previous. 11 of 33 View next.

Hepatitis C virus viremia and low platelet count: A study in a hepatitis B & C endemic area in Taiwan

Chia-Yen Dai123, Chi-Kung Ho3, Jee-Fu Huang124, Ming-Yen Hsieh1, Nai-Jen Hou14, Zu-Yau Lin12, Shinn-Cherng Chen12, Ming-Yuh Hsieh12, Liang-Yen Wang12, Wen-Yu Chang12, Ming-Lung Yu12Corresponding Author Informationemail addressemail addressemail address, Wan-Long Chuang12Corresponding Author Information

Received 8 April 2009; received in revised form 25 June 2009; accepted 27 July 2009. published online 03 December 2009.

Background & Aims

Hepatitis C virus (HCV) infection has been shown to be associated with a low platelet count. This study aimed to elucidate the association between virologic status and platelet count in individuals with HCV infection.

Methods

A large-scale survey, enrolling 11,239 residents, was conducted in the Kaohsiung area of Taiwan. Serum HCV RNA and non-invasive markers of fibrosis (FibroTest) were tested for antibody to HCV (anti-HCV)-positive subjects. The platelet counts of age- and sex-matched, biopsy-proven, hospital-based patients and community-based patients with minimal fibrosis were compared.

Results

Anti-HCV was positive in 703 (6.2%) subjects and was significantly associated with older age, female sex, abnormal alanine aminotransferase (ALT) value and low platelet count (<150,000/μl). The independent factors significantly associated with low platelet count were abnormal ALT value (odds ratio [OR]: 3.70, 95% confidence intervals [CI]: 2.18–6.28) and positive HCV RNA (OR: 2.00, 95% CI: 1.01–3.97). After adjustment for the fibrosis, HCV RNA remained significantly associated with platelet counts.

Conclusions

Our results evaluating the association between platelet count and HCV viremia and taking the influences of fibrosis into consideration implicate that platelets may be affected directly by HCV.

1 Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

2 Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

3 Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

4 Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan

Corresponding Author InformationCorresponding authors. Address: Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Rd, Kaohsiung 807, Taiwan. Tel.: +886 7 3121101x7475; fax: +886 7 3234553.

 These authors contributed equally to this work.

PII: S0168-8278(09)00793-4

doi:10.1016/j.jhep.2009.11.017


View previous. 11 of 33 View next.